← All tickers

Is REPL Worth Buying in 2026?

Replimune Group, Inc.

STOCK BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Updated 2026-08-23

Here’s whether Replimune Group, Inc. (REPL) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+12.67% over 10 days); strong 1-year return of +181.3%; 3-month momentum positive (+182.9%). Concerns: declining volume on rally — weak conviction (0.68x 30d avg). Currently 6.0% off its 52-week high. Score: +5/7.

Ready to act on this? 📈 Trade on Webull

REPL is in a confirmed uptrend, trading above both its 50-day ($11.22) and 200-day ($8.28) moving averages. An RSI of 66.0 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +181.3% compares to +20.5% for SPY (beat the market by 160.8%).

$10,000 invested 1 year ago → $28,133 today
vs. S&P 500 (SPY) — same period beat market by 160.8%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($8.28)
✓Above 50-day MA ($11.22)
✓RSI(14) neutral zone (30–70) — currently 66.0
✓Positive return (+181.3%)
✓Within 10% of period high (−6.0%)
Period Range $14.77
$1.50 $15.71
RSI (14) 66.0
0 · OversoldOverbought · 100

Key Metrics

Price$14.77
Period Return+181.3%
Period High$15.71
Period Low$1.50
Drawdown−6.0%
MA-50$11.22
MA-200$8.28
RSI (14)66.0
Avg Volume (30d)6.5M
vs. SPYbeat by 160.8%
Return Rank#71 of 999

Trade REPL

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers